TY - JOUR T1 - CP7_E2alf oral vaccination confers partial protection against early classical swine fever virus challenge and interferes with pathogeny-related cytokine responses. JF - Vet Res Y1 - 2013 A1 - Renson, Patricia A1 - Le Dimna, Mireille A1 - Keranflech, André A1 - Cariolet, Roland A1 - F. Koenen A1 - Le Potier, Marie-Frédérique KW - Adaptive Immunity KW - Administration, Oral KW - Animals KW - Antibodies, Neutralizing KW - Antibodies, Viral KW - Classical Swine Fever KW - Classical swine fever virus KW - Cytokines KW - Specific Pathogen-Free Organisms KW - Swine KW - Vaccines, Attenuated KW - Viral Vaccines AB -

The conventional C-strain vaccine induces early protection against classical swine fever (CSF), but infected animals cannot be distinguished from vaccinated animals. The CP7_E2alf marker vaccine, a pestivirus chimera, could be a suitable substitute for C-strain vaccine to control CSF outbreaks. In this study, single oral applications of CP7_E2alf and C-strain vaccines were compared for their efficacy to induce protection against a CSF virus (CSFV) challenge with the moderately virulent Bas-Rhin isolate, in pigs as early as two days post-immunization. This work emphasizes the powerful potential of CP7_E2alf vaccine administered orally by a rapid onset of partial protection similar to that induced by the C-strain vaccine. Furthermore, our results revealed that both vaccinations attenuated the effects induced by CSFV on production of the pig major acute phase protein (PigMAP), IFN-α, IL-12, IL-10, and TGF-β1 cytokines. By this interference, several cytokines that may play a role in the pathogeny induced by moderately virulent CSFV strains were revealed. New hypotheses concerning the role of each of these cytokines in CSFV pathogeny are discussed. Our results also show that oral vaccination with either vaccine (CP7_E2alf or C-strain) enhanced CSFV-specific IgG2 production, compared to infection alone. Interestingly, despite the similar antibody profiles displayed by both vaccines post-challenge, the production of CSFV-specific IgG1 and neutralizing antibodies without challenge was lower with CP7_E2alf vaccination than with C-strain vaccination, suggesting a slight difference in the balance of adaptive immune responses between these vaccines.

VL - 44 U1 - http://www.ncbi.nlm.nih.gov/pubmed/23398967?dopt=Abstract M3 - 10.1186/1297-9716-44-9 ER -